A phase I/II clinical study of DOC1021 (dubodencel) dendritic cell immunotherapy for refractory melanoma.

dubodencel (DOC1021) - Diakonos Research

https://www.asco.org/abstracts-presentations/266739

Alexandra Haugh; William Decker; Ryan Sullivan; John Dubay; Elizabeth Duus; Ian Bellayr; Laura Aguilar; Annette Molinaro; Akshar Trivedi; Wei Liu; Vanaja Konduri

Apr 21, 2026